THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Anastasiia Zherniakova, 182748

DETECTION OF JAK2 EXON 12 MUTATIONS BY HETERODUPLEX ANALYSIS AND PYROSEQUENCING

EHA Library, Tatiana Subbotina, 182749

INTRODUCTION OF AN NGS GENE PANEL INTO CLINICAL SERVICE FOR MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Anna Skowronska, 182750

IN JAK2V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS, BLEEDING RISK CORRELATES WITH ALLELE BURDEN

EHA Library, Irene Bertozzi, 182751

JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Mariasanta Napolitano, 182752

COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA.

EHA Library, Mariasanta Napolitano, 182753

LABORATORY RESPONSIVENESS OF LOW-DOSE ASPIRIN IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Rossella Cacciola, 182754

CLINICAL AND EXPERIMENTAL CHARACTERISTICS OF MYELOID/LYMPHOID NEOPLASMS DISPLAYING PDGFRA OR PDGFRB REARRANGEMENT

EHA Library, Huiying Qiu, 182755

PLATELET AGGREGATION STUDY OF ESSENTIAL THROMBOCYTHEMIA TREATED WITH ANAGRELIDE

EHA Library, Yasushi Hiramatsu, 182756

A SINGLE CENTRE EXPERIENCE OF MASTOCYTOSIS

EHA Library, Gulkan Ozkan, 182757

JAK2 PSEUDO-KINASE AND KINASE MUTATIONS IN THE ETIOLOGY OF THROMBOCYTOSIS

EHA Library, Margarida Coucelo, 182758

COMPARISONS OF PATIENT MANAGEMENT IN MYELOPROLIFERATIVE NEOPLASM PATIENTS IN THE UK VS REST OF WORLD: ANALYSIS FROM THE INTERNATIONAL LANDMARK SURVEY

EHA Library, Claire Harrison, 182759

ANALYSIS OF EMERGING MOLECULAR SIGNATURES IN MPNANALYSIS OF EMERGING MOLECULAR SIGNATURES AND ASSOCIATED CLINICAL FEATURES IN MPN

EHA Library, Salem H Al, 182760

IMPACT OF THE TYPE OF CALR MUTATIONS ON THE CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS

EHA Library, Ekaterina Lisina, 182761

THE UNIQUE CASE OF GERMLINE CEBPA MUTATION IN PATIENT WITH FIP1L1/PDGFRA ASSOCIATED MYELOID/LYMPHOID NEOPLASM WITH EOSINOPHILIA

EHA Library, Nelli Gabeeva, 182763

DEVELOPMENT AND DESIGN OF A RANDOMIZED CONTROLLED TRIAL USING ONLINE YOGA FOR SYMPTOM MANAGEMENT IN MYELOPROLIFERATIVE NEOPLASM PATIENTS

EHA Library, Jennifer Huberty, 182764

COMPARISONS OF SYMPTOM BURDEN IN MYELOPROLIFERATIVE NEOPLASM PATIENTS IN THE UK VS REST OF WORLD: ANALYSIS FROM THE INTERNATIONAL LANDMARK SURVEY

EHA Library, Claire Harrison, 182765

MPN10 SCORE AND SURVIVAL OF MOLECULARLY ANNOTATED MYELOPROLIFERATIVE NEOPLASMS (MPNS) PATIENTS; A FIRST REPORT ON AN EGYPTIAN COHORT

EHA Library, Yasser Elnahass, 182766

FINAL RESULTS FROM PEN-PV STUDY, A SINGLE-ARM PHASE 3 TRIAL ASSESSING THE EASE OF SELF-ADMINISTRATING ROPEGINTERFERON ALFA-2B USING A PRE-FILLED PEN IN POLYCYTHEMIA VERA PATIENTS

EHA Library, Heinz Gisslinger, 182767

JAK2, CALR AND MPL MUTATIONS: CORRELATION WITH PHENOTIPE DISEASE AND HISTOPATHOLOGICAL FEATURES OF BONE BIOPSY

EHA Library, Heidy , 182768

CLINICAL IMPLICATION OF QUANTITATIVE JAK2 V617F ANALYSIS WITH DROPLET DIGITAL PCR IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Eunyoung Lee, 182769

CLINICAL IMPACT OF JAK2 AND CARLETICULIN GENE MUTATIONS ON PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Mariasanta Napolitano, 182770

RUXOLITINIB IN MYELOFIBROSIS: A MULTICENTRE EXPERIENCE FROM THE EAST OF ENGLAND

EHA Library, James Russell, 182771

MONITORING OF TRANSIENT MYELOPROLIFERATIVE DISORDER AND LEUKEMIA IN DOWN’S SYNDROME : A SINGLE UNIVERSITY HOSPITAL STUDY

EHA Library, Jun Eun Park, 182772

INFECTIOUS EVENTS IN A COHORT OF PATIENTS WITH MYELOFIBROSIS UNDER TREATMENT COMPARING RUXOLITINIB WITH CONVENTIONAL THERAPY. A MONOCENTRIC EXPERIENCE OF 22 PATIENTS RETROSPECTIVELY ANALYSED.

EHA Library, Lorenza Torti, 182773

THE JAK2V617F MUTATION AND LEUKOCYTOSIS AS RISK FACTORS FOR INCIDENCE OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

EHA Library, Evica Simonovic, 182774

RISK FACTORS FOR INCIDENCE OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Evica Simonovic, 182775

CLINICAL RELEVANCE OF JAK2V617F MUTATIONAL LOAD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS FROM REPUBLIC OF MACEDONIA (SINGLE-CENTER EXPERIENCE)

EHA Library, Marija Popova Simjanovska, 182776

CSF3R T618-MUTATED CHRONIC NEUTROPHILIC LEUKEMIA: A RARE CASE SUCCESSFULLY TREATED WITH RUXOLITINIB

EHA Library, Concetta conticello, 182777

PERIPHERAL BLOOD CELL STUDY FROM PATIENTS WITH FOLLICULAR LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA: WHAT SHOULD WE EXPECT?

EHA Library, Dolores Subira, 182778

POTENTIALITY OF PDPK1 AS A THERAPEUTIC TARGET MOLECULE IN MANTLE CELL LYMPHOMA

EHA Library, Saori Maegawa, 182779

THE ACQUISITION OF RESISTANCE TO BENDAMUSTINE HYDROCHLORIDE INDUCES MULTIDRUG RESISTANCE IN A NOVEL MANTLE CELL LYMPHOMA-DERIVED CELL LINE KPUM-YY1

EHA Library, Tomoko Shimomura, 182780

COMPARISON OF OVERALL SURVIVAL ACCORDING TO BONE MARROW ASPIRATION RESULTS IN PATIENTS WITH NON-HODGKIN’S LYMPHOMA

EHA Library, Jung Yoon Choi, 182781

IN VIVO IMAGING OF LUMINESCENT DIFFUSE LARGE B-CELL LYMPHOMA XENOGRAFTS COMBINED WITH MASS SPECTROMETRY IMAGING IDENTIFY SPECIFIC MOLECULAR ALTERATION DURING R-CHOP RELAPSE.

EHA Library, Christophe COME, 182782

THE PROGNOSTIC ROLE OF INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION IN HODGKIN’S LYMPHOMA.

EHA Library, Tetiana Skrypets, 182783

SECONDARY CHROMOSOMAL ABNORMALITIES AND THEIR IMPACT ON TREATMENT OUTCOME IN PEDIATRIC BURKITT LEUKEMIA.

EHA Library, Sherine Ibrahim Salem, 182784

IGVH SOMATIC MUTATION PROFILE AS PATHOGENETIC SIGNATURE IN SPLENIC MARGINAL ZONE LYMPHOMA AND SPLENIC DIFFUSE RED PULP LYMPHOMA

EHA Library, Hunan Julhakyan, 182785

CELL OF ORIGIN ASSIGNMENT USING IMMUNOHISTOCHEMISTRY IS INFLUENCED BY BCL-2 EXPRESSION IN DLBCL PATIENTS TREATED WITH CHEMO-IMMUNOTHERAPY.

EHA Library, Moussab Damlaj, 182786

ARE DIFFERENCES BETWEEN PEDIATRIC EBV-ASSOCIATED LYMPHOMAS AND CARRIERS REGARDING LATENCY PROFILE AND MICROENVIRONMENT COMPOSITION INVOLVED IN LYMPHOMAGENESIS?

EHA Library, Paola Chabay, 182787

MICROARRAY EXPRESSION PROFILE OF LONG NONCODING RNAS IN GERMINAL CENTER-LIKE DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Zuofei Chi, 182788

FLOW CYTOMETRY IN EVALUATION OF EXTRANODAL LYMPHOMA PRESENTING AT UNUSUAL LOCATIONS COMPARED TO NODAL LYMPHOMAS

EHA Library, Pallavi Prakhar, 182789

POSSIBLE ROLE OF FLOW CYTOMETRY TO CHARACTERIZE INFILTRATING CD4 CELLS IN THE MICRO ENVIRONMENT OF LYMPHOMA TISSUE SAMPLES

EHA Library, Rosa Di Gaetano, 182790

TREG CD4 PHENOTYPE IN THE PERIPHERAL BLOOD OF LYMPHOMAS

EHA Library, Rosa Di Gaetano, 182791

BCL-2 AND KI-67 AS INDEPENDENT PREDICTORS OF POOR-RISK IPI GROUP OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Emina Suljovic Hadzimesic, 182792

COMPARATIVE PATHOLOGIC ANALYSIS OF MEDIASTINAL B-CELL LYMPHOMAS: EXPRESSION OF P63 BEST DIFFERENTIATES PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA FROM CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ji Eun Kim, 182793

CASTLEMAN`S DISEASE: HISTOLOGICAL SUBTYPES AND MICROVESSEL DENSITY

EHA Library, Natalya Semenova, 182794

PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL MARKERS IN R-CHOP TREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS

EHA Library, Ana-Maria Patrascu, 182795

LYMPHOID NEOPLASMS: A REALLY IMPORTANT TRIGGER IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Violeta Martinez-Robles, 182796

MARIH, A NATIONAL NETWORK FOR RARE IMMUNOHEMATOLOGICAL DISORDERS

EHA Library, Amélie Marouane, 182797

CLINICAL FEATURES AND ETIOLOGY OF PATIENTS WITH THROMBOTIC MICROANGIOPATHIES

EHA Library, Ulku Ergene, 182798

HAEMOLYSIS AS SCREENING TEST IN LYSOSOMAL STORAGE DISEASES

EHA Library, Laura López De, 182799

CLINICAL SIGNIFICANCE OF ELEVATED SERUM COBALAMIN (VITAMIN B12) LEVELS

EHA Library, Selin Aytac, 182800

THE HEMATOLOGIC FINDINGS OF INHERITED METABOLIC DISEASE; THEY ARE MORE THAN EXPECTED

EHA Library, Idil Yenicesu, 182801

HEMATOTOXIC EFFECTS OF GENERIC TRIAZOLE FUNGICIDES TEBUCONAZOLE ON WISTAR HANNOVER RATS

EHA Library, Tetiana Usenko, 182802

WHAT WE CAN DO TO MAKE A STANDARDIZATION AND HARMONIZATION OF APTT?

EHA Library, Merve , 182803

ACQUIRED PURE RED CELL APLASIA IN AN ADOLESCENT: COULD IT BE ANYTHING ELSE?

EHA Library, Ozlem Tufekci, 182804

APLASTIC ANEMIA IN CHILDHOOD: A TEN YEARS' SINGLE CENTER EXPERIENCE

EHA Library, Athanasia Apsemidou, 182805

CAUSES OF IRON DEFICIENCY ANEMIA IN THE HEMATOLOGY CLINIC - SINGLE CENTER EXPERIENCE

EHA Library, Mihai Ionita, 182806

IMPACTS OF CLINICAL AND BIOCHEMICAL PARAMETERS ON KEY HEMATOLOGICAL INDICES IN ADULTS: A COHORT STUDY

EHA Library, Chih-Cheng Chen, 182807

UNUSUAL DISTRIBUTION OF INTERLEUKIN-10 C-592A GENE POLYMORPHISM IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA FROM NORTH-WESTERN RUSSIA

EHA Library, Sergey Kapustin, 182808

COMBINED TREATMENT OF AZATHIOPRINE AND ROMIPLOSTIM IN PATIENTS ITP REFRACTORY TO STEROIDS OR THROMBOPOIETIN ANALOGS.

EHA Library, Maria Eva Mingot Castellano, 182809

AGONIST-INDUCED PLATELET REACTIVITY CORRELATES WITH BLEEDING IN HEMATO-ONCOLOGICAL PATIENTS

EHA Library, Birol Batman, 182810

TUMOR NECROSIS FACTOR-Α AND TUMOR NECROSIS FACTOR-Β SINGLE NUCLEOTIDE POLYMORPHISM AND CHRONICITY IN EGYPTIAN PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA.

EHA Library, Mona El-Ghamrawy, 182811

PROGNOSTIC FACTORS IN PRIMARY IMMUNE THROMBOCYTOPENIA OF CHILDHOOD

EHA Library, Alexandros Makis, 182812

CANCER-ASSOCIATED IMMUNE THROMBOCYTOPENIA

EHA Library, Gustavo Alberto PINTO SOLANO, 182813

THE ROLE OF MEAN PLATELET VOLUME IN NEONATAL SEPSIS: A RETROSPECTIVE CASE CONTROL STUDY IN A LEVEL III NEONATAL INTENSIVE CARE UNIT.

EHA Library, Anand Srinivasan, 182814

IS PLATELET TRANSFUSION WARRANTED IN PATIENTS WITH ACUTE TTP REQUIRING CENTRAL VENOUS CATHETER INSERTION?

EHA Library, Ryan Low, 182815

LONG-TERM EFFICACY AND SAFETY OF THROMBOPOIETIN AGONISTS IN ADULT REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Eleni Gavriilaki, 182816

VITAMIN D RECEPTOR GENE POLYMORPHISMS IN ADULT PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Mohamed Sakr, 182817

A SURVEY OF THE TREATMENT OF THE PREVENTION OF NAIT IN THE UK AND IRELAND

EHA Library, Valerie Broderick, 182818

THE EVALUATION OF REACTIVE OXYGEN SPECIES IN CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA AND HELICOBACTER PYLORI INFECTION VERSUS CHRONIC ITP WITHOUT HELICOBACTER PYLORI INFECTION

EHA Library, Mihnea-Alexandru Găman, 182819

IMMUNE THROMBOCYTOPENIA AND PREGNANCY: A SPANISH CASE SERIES OF 270 PREGNANCIES IN PRIMARY ITP.

EHA Library, Tomás José González-López, 182820

ANALYSIS OF THE DEMOGRAPHIC, CLINICAL, LABORATORY AND TREATMENT-RELATED DATA OF ITP PATIENTS IN GREECE BASED ON THE NATIONAL ITP REGISTRY OF THE HELLENIC SOCIETY OF HAEMATOLOGY

EHA Library, Emily Stavroulaki, 182821

PRESENTING SYMPTOMS AFFECT OUTCOME IN IMMUNE MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Jahanzaib Khwaja, 182822

NOVEL TECHNIQUES FOR MONITORING GALNZMANN THROMBASTENIA PATIENT UNDERGOING SURGICAL INTERVENTIONS.

EHA Library, Assaf Barg, 182823

CAN HISTOCHEMICAL C-MPL POSITIVITY IN BONE MARROW BE A PREDICTOR FOR SPLENECTOMY IN IMMUNE THROMBOCYTOPENIA?

EHA Library, Zahit Bolaman, 182824

CLINICAL SIGNIFICANCE OF IMMATURE PLATELET FRACTION (IPF) MEASUREMENT IN THROMBOCYTOPENIC DISORDERS DURING PREGNANCY

EHA Library, Rosa Collado Nieto, 182825

DOES EARLY RESPONSE TO FIRST LINE CORTICOSTEROID THERAPY PREDICT REQUIREMENT FOR SECOND LINE THERAPY IN IMMUNE THROMBOCYTOPENIA?

EHA Library, Selin Kucukyurt Kaya, 182826

THE IMPACT OF FC GAMMA RECEPTOR IIA AND IIIA GENE POLYMORPHISMS ON THE THERAPEUTIC RESPONSE OF RITUXIMAB IN EGYPTIAN ADULT IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Hend Ellithy, 182827

IMMUNE THROMBOCYTOPENIA. EGYPTIAN EXPERIENCE WITH STUDY OF IL-17,TGFB, IL-35 AND IL-12 CYTOKINES IN CHRONIC AND PERSISTENT IMMUNE THROMBOCYTOPENIA PATIENTS.

EHA Library, Noha El Husseiny, 182828

SWITCH OF TPO-MIMETICS IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA:FLORENCE MONOCENTRIC EXPERIENCE.

EHA Library, Caterina Biagiotti, 182829

COEXISTENCE OF GLANZMANN'S THROMBASTHENIA AND MAPLE SYRUP URINE DISEASE (MSUD): IMPLICATIONS FOR HEMOSTATIC MANAGEMENT.

EHA Library, Mohamed Elshinawy, 182830

ASSESSMENT OF PLATELET REACTIVITY TO ASPIRIN AND CLOPIDOGREL WITH POINT-OF-CARE VERIFYNOW® ASSAY AND TWO ALTERNATIVE METHODS IN PATIENTS WITH CEREBRAL ANEURYSMS TREATED WITH ENDOVASCULAR PROCEDURES

EHA Library, Diego Velasco-Rodríguez, 182831

THROMBOPOIETIN-RECEPTOR AGONISTS IN ITP - EXPERIENCE OF A CENTER

EHA Library, Maria Jose Teles, 182832

VARIATIONS IN PARAMETRES OF PLATELET COUNT AND PLATELET VOLUME ACCORDING TO GESTATIONAL AGE

EHA Library, Saadet Akarsu, 182833

RISK OF LUPUS AFTER PRIMARY IMMUNE THROMBOCYTOPENIC PURPURA: A 14 YEAR SINGLE CENTER EXPERIENCE

EHA Library, Mahmoud Ayesh (Haj Yousef), 182834

TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIA WITH THROMBOPOIETIN RECEPTOR AGONISTS: OUR EXPERIENCE IN CHILDHOOD

EHA Library, Joud , 182835

INVESTIGATION OF PLATELET FUNCTIONS IN PSEUDOTHROMBOCYTOPENIA

EHA Library, Birgul Onec, 182836

MANAGEMENT OF ADULT CHRONIC IMMUNE THROMBOCYTOPENIA.SINGLE CENTER EXPERIENCE

EHA Library, Ioana Ionita, 182837

IMMUNOLOGICAL THROMBOCYTOPENIC PURPURA AND PREGNANCY: A RETROSPECTIVE STUDY OF 89 PREGNANCIES IN 59 PATIENTS.

EHA Library, Hamida Brahimi, 182838

QUALITY OF LIFE AND SYMPTOM BURDEN IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, S.M.Amine BENLAZAR, 182839

QUALITY OF LIFE IN ANEMIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Nikolay Romanenko, 182840

AN ANLYSIS OF THE IMPACT OF LOCAL COSTS OF MEDICINES ON COST EFFECTIVENESS OF THE TREATMENT OF CANCER ASSOCIATED THROMBOSIS.

EHA Library, Elisabeth Reimer, 182841

MINIMIZING THE RISK OF MUCOSITIS IN HEMATOLOGIC PATIENTS WITH TOPICAL PRODUCTS

EHA Library, Iulia Ursuleac, 182842

EUROBLOODNET: THE EUROPEAN REFERENCE NETWORK IN RARE HEMATOLOGICAL DISEASES

EHA Library, MARIA DEL MAR MANU PEREIRA, 182843

2016 REVISION OF WHO CLASSIFICATION OF TUMOURS OF HAEMATOPOETIC AND LYMPHOID TISSUES: IMPACT ON INVESTIGATING PATIENTS WITH ISCHAEMIC STROKE

EHA Library, Chepsy Cherian Philip, 182844

PATHOPHYSIOLOGICAL MECHANISMS INVOLVED IN THE DEVELOPMENT OF ANEMIA IN PATIENTS WITH NON-HODGKIN’S LYMPHOMA

EHA Library, Mihnea-Alexandru Găman, 182845

SAFETY OF RITUXIMAB BIOSIMILAR (NOVEX®) IN THE ROUTINE USE TREATMENT IN ARGENTINA.

EHA Library, Gustavo Milone, 182846

DEPRESSION AS THE PRESENTING SYMPTOM OF CENTRAL NERVOUS SYSTEM LYMPHOMAS IN NORTHWESTERN TURKEY

EHA Library, Elif Umit, 182847

IMPACT OF U.S. FDA APPROVAL OF LENALIDOMIDE MAINTENANCE THERAPY IN THE FIRST-LINE TREATMENT OF MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT ON TOTAL HEALTHCARE COSTS

EHA Library, Safiya Abouzaid, 182848